Drug Pricing

Welch gets commitment from Secretary Kennedy to work on bipartisan Welch-Hawley bill to lower prescription drug prices for Americans  WASHINGTON, D.C.— In a Senate Finance Committee hearing today, U.S. Senator Peter Welch (D-Vt.) took Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to task for the Trump Administration’s failure to lower prescription drug prices for everyday Americans. Senator Welch grilled Secretary Kennedy on how TrumpRx—the Trump…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, released the following statement on the launch of TrumpRx, a new direct-to-consumer prescription drug platform launched by the Trump Administration:  “TrumpRx is yet another PR stunt and a money-making scheme for the Trump family. American seniors and patients will (once again) be left…

As Drug Prices Continue to Go Up and Republicans Give Hand Outs to Big Pharma, Democrats Offer Bold Vision to Lower Drug Costs for All Americans WASHINGTON, D.C. — Today, U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, joined Ranking Member of the Senate Finance…

Senators request answers on structure of “TrumpRx” and how recent drug pricing agreements will impact Medicare and Medicaid benefits  WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, this week led six Senate Democrats in demanding transparency from the…

WASHINGTON, D.C.—Finance Committee members Senator Peter Welch (D-Vt.) and Catherine Cortez Masto (D-Nev.), alongside Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today introduced the No Big Blockbuster Bailouts Act (NOBBBA), a bill to reverse Republicans’ policies in the so-called ‘One Big Beautiful Bill Act’…